---
figid: PMC4034544__nihms-576870-f0001
figlink: /pmc/articles/PMC4034544/figure/F1/
number: Figure 1
caption: MAPK pathway signaling in malignant melanoma leads to phosphorylation and
  activation of RAS, RAF, MEK, and ERK, a process that ultimately regulates the cell
  cycle, differentiation, and apoptosis. Mutated BRAF, which is 500-fold activated,
  stimulates constitutive signaling, proliferation, and survival, making it an excellent
  target for vemurafenib and dabrafenib. Trametinib inhibits MEK, situated downstream.
  MAPK = mitogen-activated protein kinase
pmcid: PMC4034544
papertitle: Latest Advances in Chemotherapeutic, Targeted and Immune Approaches in
  the Treatment of Metastatic Melanoma.
reftext: Darshil J. Shah, et al. Mayo Clin Proc. ;89(4):504-519.
pmc_ranked_result_index: '12855'
pathway_score: 0.9327345
filename: nihms-576870-f0001.jpg
figtitle: MAPK pathway signaling in malignant melanoma leads to phosphorylation and
  activation of RAS, RAF, MEK, and ERK, a process that ultimately regulates the cell
  cycle, differentiation, and apoptosis
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4034544__nihms-576870-f0001.html
  '@type': Dataset
  description: MAPK pathway signaling in malignant melanoma leads to phosphorylation
    and activation of RAS, RAF, MEK, and ERK, a process that ultimately regulates
    the cell cycle, differentiation, and apoptosis. Mutated BRAF, which is 500-fold
    activated, stimulates constitutive signaling, proliferation, and survival, making
    it an excellent target for vemurafenib and dabrafenib. Trametinib inhibits MEK,
    situated downstream. MAPK = mitogen-activated protein kinase
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK12
  - SOS1
  - MAPK10
  - NRAS
  - SHC1
  - MAPK3
  - MAPK13
  - MAPK11
  - MAPK1
  - MAPK14
  - SHC2
  - SOS2
  - KRAS
  - MAP2K2
  - MAPK8
  - MAPK9
  - SHC4
  - SHC3
  - MAP2K1
  - HRAS
  - BRAF
  - Trametinib
  - Dabrafenib
  - Noonan syndrome
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals:
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Dabrafenib
  source: MESH
  identifier: C561627
diseases:
- word: Noonan syndrome
  source: ''
  identifier: ''
---
